Annual EBITDA
$3.22B$1.35B-29.49%
Summary
- Current Value
- As of today, VTRS annual EBITDA is $3.22B, down -29.49% on
- Historical Performance
- VTRS annual EBITDA is down -39.93% over the past 3 years, down -9.88% over the past 5 years
- All-Time High Comparison
- VTRS annual EBITDA is currently -39.93% below its historical high of $5.36B set on
- 3-Year Low Comparison
- VTRS annual EBITDA is at its 3-year low
- Sector Comparison
- VTRS annual EBITDA is higher than 96.55% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.22B | -29.5% | -39.9% | -9.9% | +150.3% | |
| Quarterly EBITDA | $1.02B | +21.5% | -16.2% | -38.7% | +175.3% | |
| TTM EBITDA | $4.12B | +11.7% | -20.4% | -3.1% | +205.5% | |
| Price | $16.29 | +89.6% | +78.8% | +6.9% | -30.4% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $14.29B | -2.8% | -11.6% | +19.7% | +162.3% | |
| Annual EPS | -$3.00 | -464.9% | -275.9% | -169.4% | -541.5% | |
| $423.50M | -77.2% | -83.1% | -68.8% | -51.0% | ||
| Annual Net Income | -$3.51B | -454.2% | -269.1% | -424.7% | -1117.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.36B | N/A | -39.9% |
| 5Y | $5.36B | -39.9% | |
| All | $5.36B | -39.9% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $3.22B | at low | |
| 5Y | $3.22B | at low | |
| All | $2.32M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of VTRS?
As of today, VTRS annual EBITDA is $3.22B
What is 1-year change in VTRS annual EBITDA?
VTRS annual EBITDA is down -29.49% year-over-year
What is 3-year change in VTRS annual EBITDA?
VTRS annual EBITDA is down -39.93% over the past 3 years
How far is VTRS annual EBITDA from its all-time high?
VTRS annual EBITDA is currently -39.93% below its historical high of $5.36B set on December 31, 2022
How does VTRS annual EBITDA rank versus sector peers?
VTRS annual EBITDA is higher than 96.55% of companies in Healthcare sector
When is VTRS next annual earnings release?
As of today, the next annual earnings release for VTRS has not been scheduled
Quarterly EBITDA
$1.02B$31.60M-3.00%
Summary
- Current Value
- As of today, VTRS quarterly EBITDA is $1.02B, down -3.00% on
- Historical Performance
- VTRS quarterly EBITDA is up +21.53% year-over-year, down -16.24% over the past 3 years
- All-Time High Comparison
- VTRS quarterly EBITDA is currently -39.29% below its historical high of $1.68B set on
- 3-Year Low Comparison
- VTRS quarterly EBITDA is +30.17% above its 3-year low of $785.80M reached on
- Sector Comparison
- VTRS quarterly EBITDA is higher than 96.95% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.02B | -3.0% | +21.5% | -16.2% | -38.7% | |
| Annual EBITDA | $3.22B | – | -29.5% | -39.9% | -9.9% | |
| TTM EBITDA | $4.12B | +4.6% | +11.7% | -20.4% | -3.1% | |
| Price | $16.29 | +9.1% | +89.6% | +78.8% | +6.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $3.52B | -5.0% | +8.5% | -5.4% | -20.4% | |
| Quarterly EPS | $0.15 | +150.9% | +105.9% | -19.5% | +117.5% | |
| $346.80M | +20.5% | +95.9% | -29.4% | +40.7% | ||
| Quarterly Net Income | $176.40M | +151.9% | +105.8% | -21.5% | +117.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.05B | -3.0% | |
| 3Y | $1.22B | -16.3% | |
| 5Y | $1.68B | -39.3% | |
| All | $1.68B | -39.3% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $841.70M | N/A | +21.5% |
| 3Y | $785.80M | +30.2% | |
| 5Y | $785.80M | +30.2% | |
| All | -$56.49M | +1910.6% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of VTRS?
As of today, VTRS quarterly EBITDA is $1.02B
What is VTRS quarterly EBITDA most recent change?
VTRS quarterly EBITDA was down -3.00% on March 31, 2026
What is 1-year change in VTRS quarterly EBITDA?
VTRS quarterly EBITDA is up +21.53% year-over-year
How far is VTRS quarterly EBITDA from its all-time high?
VTRS quarterly EBITDA is currently -39.29% below its historical high of $1.68B set on June 30, 2021
How does VTRS quarterly EBITDA rank versus sector peers?
VTRS quarterly EBITDA is higher than 96.95% of companies in Healthcare sector
When is VTRS next earnings release?
The next earnings release for VTRS is on
TTM EBITDA
$4.12B$181.20M+4.60%
Summary
- Current Value
- As of today, VTRS TTM EBITDA is $4.12B, up +4.60% on
- Historical Performance
- VTRS TTM EBITDA is up +11.74% year-over-year, down -20.36% over the past 3 years
- All-Time High Comparison
- VTRS TTM EBITDA is currently -33.56% below its historical high of $6.20B set on
- 3-Year Low Comparison
- VTRS TTM EBITDA is +11.74% above its 3-year low of $3.69B reached on
- Sector Comparison
- VTRS TTM EBITDA is higher than 96.95% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.12B | +4.6% | +11.7% | -20.4% | -3.1% | |
| Annual EBITDA | $3.22B | – | -29.5% | -39.9% | -9.9% | |
| Quarterly EBITDA | $1.02B | -3.0% | +21.5% | -16.2% | -38.7% | |
| Price | $16.29 | +9.1% | +89.6% | +78.8% | +6.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $14.57B | +1.9% | +2.1% | -7.3% | +6.0% | |
| TTM EPS | -$0.26 | +91.3% | +91.8% | -116.6% | +82.7% | |
| $1.31B | +14.9% | +59.7% | -39.1% | +27.2% | ||
| TTM Net Income | -$296.50M | +91.6% | +92.2% | -115.6% | +82.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.12B | at high | |
| 3Y | $5.18B | N/A | -20.4% |
| 5Y | $6.20B | -33.6% | |
| All | $6.20B | -33.6% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.69B | N/A | +11.7% |
| 3Y | $3.69B | +11.7% | |
| 5Y | $3.69B | +11.7% | |
| All | -$56.49M | +7395.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of VTRS?
As of today, VTRS TTM EBITDA is $4.12B
What is VTRS TTM EBITDA most recent change?
VTRS TTM EBITDA was up +4.60% on March 31, 2026
What is 1-year change in VTRS TTM EBITDA?
VTRS TTM EBITDA is up +11.74% year-over-year
How far is VTRS TTM EBITDA from its all-time high?
VTRS TTM EBITDA is currently -33.56% below its historical high of $6.20B set on December 31, 2021
How does VTRS TTM EBITDA rank versus sector peers?
VTRS TTM EBITDA is higher than 96.95% of companies in Healthcare sector
When is VTRS next earnings release?
The next earnings release for VTRS is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- VTRS Official Website www.viatris.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1792044/000179204426000013/0001792044-26-000013-index.htm
- VTRS Profile on Yahoo Finance finance.yahoo.com/quote/VTRS
- VTRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vtrs